Your daily source for curated top headlines featuring the day’s biggest stories and standout moments.
ADB Unveils Minerals-to-Manufacturing Facility To Boost Asia-Pacific Critical Mineral Supply Chains
Christopher Mellon to Headline 2026 SCU Conference on Unidentified Anomalous Phenomena as 19 Scientists Convene
EIN Presswire
Former Pentagon Intelligence Leader to Deliver Keynote at “The Role of Science and Global Governments in UAP Research,” July 24–26 in Toronto.
Western Star Files Application With U.S. Defense Industrial Base Consortium as Tungsten Prices Rip and the West Scrambles for Non-China Supply
GlobeNewswire, Inc.
A submission into a U.S. DoW critical minerals solicitation, an inbound IR engagement targeting the European market, and a flow-through financing arrive in the middle of a tungsten supercycle — and 8 months before the U.S. defense procurement ban...
America Relies on China for 100% of 15 Critical Minerals — One Man Says That’s About to Change
GlobeNewswire, Inc.
Baltimore, MD, May 04, 2026 (GLOBE NEWSWIRE) -- The United States currently depends on China for 100% of its supply of 15 critical minerals.
Nexxen and ADvolution Bring Influencer Engagement to Programmatic Political Campaigns
GlobeNewswire, Inc.
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Nexxen (NASDAQ: NEXN), the advertising technology platform powered by unique data and media, today announced an exclusive partnership with fandom intelligence provider ADvolution to make audience segments...
Swarmer Partners With Rakuten to Enter Japan's Advanced Autonomy Market
GlobeNewswire, Inc.
AUSTIN, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (“Swarmer” or the “Company”) (Nasdaq: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in Ukraine since April 2024, has announced...
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
GlobeNewswire, Inc.
Post-closing combined company has revenue-producing commercial asset and a robust pipeline of products and product candidates to address multiple therapeutic areas with a focus on fibrosis and inflammatory diseases.
Video Stories
Sign up for Asia Pacific News Journal.
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.